![Matthew Perraton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 21 960 $ al 31/08/2026
Mr. Matthew Perraton is on the Board of Directors at Theralase Technologies, Inc. Mr. Perraton was previously employed as a Financial Planner by TD Waterhouse Canada, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/08/2026 | 166.360 ( 0,06 % ) | 21 960 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
TD Waterhouse Canada, Inc.
 TD Waterhouse Canada, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Theralase Technologies, Inc.
 Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
TD Waterhouse Canada, Inc.
TD Waterhouse Canada, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
